When follicular lymphoma transforms into a more aggressive form (most commonly diffuse large B-cell lymphoma, or DLBCL), it does change the treatment approach and can affect outlook. This transformation happens in a portion of people with follicular lymphoma over time. Treatment options for transformed lymphoma typically Show Full Answer
When follicular lymphoma transforms into a more aggressive form (most commonly diffuse large B-cell lymphoma, or DLBCL), it does change the treatment approach and can affect outlook. This transformation happens in a portion of people with follicular lymphoma over time. Treatment options for transformed lymphoma typically become more intensive and may include:
- Combination chemotherapy such as R-CHOP (rituximab plus several chemotherapy drugs)
- R-Bendamustine (rituximab combined with bendamustine)
- CAR T-cell therapy, which is an emerging and promising option
- Bone marrow transplant — either using your own cells (autologous) or a donor's cells (allogeneic)
- Immunotherapy to help your immune system fight the cancer Regarding life expectancy after transformation, outcomes vary widely depending on factors like age, overall health, and how well the lymphoma responds to treatment. CAR T-cell therapy in particular is showing encouraging early results, though long-term data is still emerging.
It's really important to have an open conversation with your oncologist about your specific situation, as individual factors make a big difference in predicting outcomes. Your care team can give the most personalized picture of what to expect.
May 1
Join
Your Privacy Choices
